---
title: "Sleep Duration and Mortality in US Adults With Heart Disease — NHIS-NDI Cohort Findings"
id: "plos-one-14-sleep-duration-and-cause-specific-mortality-among-us-adults-with-heart-disease"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-14-sleep-duration-and-cause-specific-mortality-among-us-adults-with-heart-disease"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657"
published_at: "2026-11-13T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Sleep Duration and Mortality in US Adults With Heart Disease — NHIS-NDI Cohort Findings
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-14-sleep-duration-and-cause-specific-mortality-among-us-adults-with-heart-disease
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657)
- **Published At:** 2026-11-13T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The study analyzed 3,287 US adults with self-reported **heart disease** from the 2004 National Health Interview Survey linked to the National Death Index through December 31, 2019. Follow-up extended up to 15 years. - Sleep was self-reported using a single question on average hours in a 24-hour period and classified as ≤6 hours (short), 7–8 hours (reference), and ≥9 hours (long). Continuous modeling using restricted cubic splines was also performed. - During follow-up, 49.4% of participants died. Deaths included 16.7% from heart-related causes and 32.6% from non-heart-related causes. These cause-specific endpoints used ICD-10 coding for heart disease. - Compared with 7–8 hours, **long sleep duration (≥9 hours)** was associated with higher hazards for all-cause mortality (HR 1.51; 95% CI 1.32–1.73), heart-related mortality (HR 1.53; 95% CI 1.22–1.92), and non-heart-related mortality (HR 1.50; 95% CI 1.27–1.77). - Restricted cubic spline analyses indicated a nonlinear relationship, with the lowest predicted mortality occurring near 6–7 hours of sleep rather than at the 7–8 hour reference category. - Investigators stratified Cox models for variables violating proportional-hazards assumptions and conducted subgroup and sensitivity analyses; reported associations remained robust across age and sex subgroups and multiple sensitivity checks. - The authors argued that **sleep duration** may serve as an accessible marker of residual risk among adults living with **heart disease**, but the report does not provide causal proof or detailed mechanistic explanations. - The data source was publicly available NHIS linked to NDI; the study had no new human or animal data collection and authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[ Skip to main content ](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#main-content) Advertisement * [plos.org](https://plos.org/) * [Create account](https://community.plos.org/registration/new) * [Sign in](https://journals.plos.org/user/secure/login?page=%2Fplosone%2Farticle%3Fid%3D10.1371%2Fjournal.pone.0362657) * * About * Browse * Publish * [](https://journals.plos.org/plosone/ "PLOS One") * Search [advanced search](https://journals.plos.org/plosone/search) * [Browse Topics](https://journals.plos.org/plosone/subjectAreaBrowse) Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click [here](https://github.com/PLOS/plos-thesaurus/blob/master/README.md "Link opens in new window"). [](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657) [](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657) * 0 [Save](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#savedHeader) [Total Mendeley and Citeulike bookmarks.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#savedHeader) * 0 [Citation](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#citedHeader) [Paper's citation count computed by Dimensions.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#citedHeader) * 55 [View](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#viewedHeader) [PLOS views and downloads.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#viewedHeader) * 0 [Share](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#discussedHeader) [Sum of Facebook, Twitter, Reddit and Wikipedia activity.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657#discussedHeader) Open Access Peer-reviewed Research Article # Sleep duration and cause-specific mortality among US adults with heart disease: A NHIS-NDI linkage cohort study * Tolulope Victoria Adebile , Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Software, Visualization, Writing – original draft, Writing – review & editing * E-mail: tolulopeadebile@gmail.com (TVA); lyu@georgiasouthern.edu (LY) Affiliations Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America, Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States of America [ ![ORCID logo](https://journals.plos.org/resource/img/orcid_16x16.png) https://orcid.org/0000-0003-3064-327X ](https://orcid.org/0000-0003-3064-327X "ORCID Registry") ⨯ * Tobi Oloyede , Contributed equally to this work with: Tobi Oloyede, Emmanuel Azu, Mobolaji Olagunju Roles Writing – original draft, Writing – review & editing Affiliation Department of Health Policy and Community Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America [ ![ORCID logo](https://journals.plos.org/resource/img/orcid_16x16.png) https://orcid.org/0000-0003-4134-4996 ](https://orcid.org/0000-0003-4134-4996 "ORCID Registry") ⨯ * Emmanuel Azu , Contributed equally to this work with: Tobi Oloyede, Emmanuel Azu, Mobolaji Olagunju Roles Writing – original draft, Writing – review & editing Affiliation Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America ⨯ * Mobolaji Olagunju , Contributed equally to this work with: Tobi Oloyede, Emmanuel Azu, Mobolaji Olagunju Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing Affiliation Epidemiology and Biostatistics Department, School of Public Health, Nanjing Medical University, Nanjing, China ⨯ * Olamide Asifat , Roles Writing – original draft, Writing – review & editing ¶‡ OA, TMP, OI, WA and PB also contributed equally to this work. Affiliation Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America ⨯ * Temitayo Mary Paul , Roles Conceptualization, Supervision, Writing – review & editing ¶‡ OA, TMP, OI, WA and PB also contributed equally to this work. Affiliation Internal Medicine, Mercy One Hospital, Des Monies, Iowa, United States of America ⨯ * Oluwaseun Ipede , Roles Writing – review & editing ¶‡ OA, TMP, OI, WA and PB also contributed equally to this work. Affiliation Department of Geology and Geography, Georgia Southern University, Statesboro, Georgia, United States of America [ ![ORCID logo](https://journals.plos.org/resource/img/orcid_16x16.png) https://orcid.org/0009-0007-0184-217X ](https://orcid.org/0009-0007-0184-217X "ORCID Registry") ⨯ * Wandoo Abwa , Roles Writing – review & editing ¶‡ OA, TMP, OI, WA and PB also contributed equally to this work. Affiliation Department of Health Policy and Community Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America ⨯ * Purbasha Biswas , Roles Methodology, Software ¶‡ OA, TMP, OI, WA and PB also contributed equally to this work. Affiliation Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America ⨯ * Lili Yu Roles Methodology, Resources, Software * E-mail: tolulopeadebile@gmail.com (TVA); lyu@georgiasouthern.edu (LY) Affiliation Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia, United States of America ⨯ # Sleep duration and cause-specific mortality among US adults with heart disease: A NHIS-NDI linkage cohort study * Tolulope Victoria Adebile, * Tobi Oloyede, * Emmanuel Azu, * Mobolaji Olagunju, * Olamide Asifat, * Temitayo Mary Paul, * Oluwaseun Ipede, … * Wandoo Abwa, * Purbasha Biswas, * Lili Yu ![PLOS](https://journals.plos.org/resource/img/logo-plos-full-color.svg) x * Published: November 13, 2026 * * [Article](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657) * [Authors](https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0362657) * [Metrics](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0362657) * [Comments](https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0362657) * [Media Coverage](http://plos.altmetric.com/details/doi/10.1371/journal.pone.0362657) * [Abstract](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#abstract0) * [Introduction](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#sec005) * [Materials and methods](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#sec006) * [Results](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#sec012) * [Discussion](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#sec016) * [Supporting information](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#sec017) * [Acknowledgments](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#ack) * [References](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#references) * [Reader Comments](https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0362657) * [Figures](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657) ## Abstract ### Background Sleep duration is increasingly recognized as a component of cardiovascular health, yet its prognostic significance among adults with established heart disease remains unclear. We examined associations between sleep duration and mortality among US adults with heart disease. ### Methods We analyzed data from 3,287 adults with heart disease participating in the 2004 National Health Interview Survey linked to the National Death Index through December 31, 2019. Sleep duration was categorized as ≤6 hours, 7–8 hours, and ≥9 hours. Cox proportional hazards models stratified by variables violating the proportional hazards assumption estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause, heart-related, and non-heart-related mortality. Restricted cubic splines evaluated nonlinear dose-response relationships. ### Results During 15 years of follow-up, 49.4% of participants died, including 16.7% from heart-related causes and 32.6% from non-heart-related causes. Compared with 7–8 hours of sleep, long sleep duration (≥9 hours) was associated with higher risks of all-cause mortality (HR:1.51 [95% CI:1.32–1.73]), heart-related mortality (HR:1.53 [95% CI:1.22–1.92]), and non-heart-related mortality (HR:1.50 [95% CI:1.27–1.77]). Restricted cubic spline analyses demonstrated nonlinear associations, with the lowest predicted mortality risk occurring at 6–7 hours. Findings remained robust across multiple sensitivity analyses and age and sex subgroups. ### Conclusions Among US adults with heart disease, long sleep duration was consistently associated with higher risks of all-cause, heart-related, and non-heart-related mortality. Sleep duration may represent a simple marker of residual risk that could enhance risk stratification among adults living with heart disease. ## Figures ![Table 3](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.t003) ![Fig 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.g002) ![Table 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.t001) ![Fig 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.g001) ![Table 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.t002) ![Table 3](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.t003) ![Fig 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.g002) ![Table 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.t001) ![Fig 1](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.g001) ![Table 2](https://journals.plos.org/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0362657.t002) **Citation:** Adebile TV, Oloyede T, Azu E, Olagunju M, Asifat O, Paul TM, et al. (2026) Sleep duration and cause-specific mortality among US adults with heart disease: A NHIS-NDI linkage cohort study. PLoS One 21(11): e0362657. https://doi.org/10.1371/journal.pone.0362657 **Editor:** Tsuo-Hung Lan, National Yang Ming Chiao Tung University School of Medicine, TAIWAN **Received:** July 8, 2026; **Accepted:** October 28, 2026; **Published:** November 13, 2026 **Copyright:** © 2026 Adebile et al. This is an open access article distributed under the terms of the [Creative Commons Attribution License](http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. **Data Availability:** No data was generated by this study. The following existing data sources were used: NHIS and NDI from CDC available via and . **Funding:** Research reported in this publication was supported by National Science Foundation award DMS-2515361 to Lili Yu. **Competing interests:** The authors have declared that no competing interests exist. ## Introduction Heart disease remains the leading cause of death in the United States (US), contributing substantially to premature mortality, disability, and health care costs despite major advances in prevention and treatment [[1](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref001),[2](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref002)]. As survival improves, a growing number of adults are living with a history of heart disease and remain vulnerable to recurrent events, functional decline, multimorbidity, and premature death [[1](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref001),[3](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref003)]. Historically, clinical management has focused on controlling traditional cardiovascular risk factors such as hypertension, diabetes, dyslipidemia, and smoking. However, growing recognition that these factors alone do not fully explain long-term outcomes among this high-risk population has prompted a broader shift toward lifestyle-based approaches to secondary prevention and risk stratification, focusing on modifiable health behaviors [[1](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref001)]. A particularly attractive candidate for lifestyle prescription is sleep duration because it is low-cost, scalable, routinely assessable, and potentially modifiable [[4](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref004),[5](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref005)]. Sleep plays a critical role in metabolic regulation, inflammation, autonomic function, and cardiovascular recovery, and accumulating evidence links both short and long sleep duration with adverse health outcomes, including incident cardiovascular diseases and premature mortality in the general population [[4](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref004)–[10](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref010)]. Long sleep duration has also been associated with increased mortality among individuals with chronic noncommunicable disease populations [[11](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref011)], while healthier multidimensional sleep patterns (e.g., adequate sleep duration) have been associated with lower risks of cardiovascular diseases and all-cause mortality among adults with diabetes [[12](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref012)]. Adults living with heart disease remain at elevated risk of premature mortality despite substantial advances in cardiovascular prevention and treatment. Identifying simple and scalable markers of residual risk is therefore an important priority for both clinical care and population health. Sleep duration is increasingly recognized as a component of cardiovascular health, yet its prognostic relevance among individuals with established heart disease remains incompletely understood. In particular, it remains unclear whether sleep duration is associated similarly across all-cause, heart-related, and non-heart-related mortality outcomes and whether these relationships follow the nonlinear patterns observed in the general population and among US patients with chest pain [[13](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref013),[14](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref014)]. However, evidence remains limited among adults with established heart disease, particularly regarding whether sleep duration is associated similarly with all-cause, heart-related, and non-heart-related mortality outcomes [[14](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref014),[15](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref015)]. Using nationally representative data from the National Health Interview Survey linked to the National Death Index, we examined associations between sleep duration and all-cause, heart-related, and non-heart-related mortality among US adults with heart disease. We additionally evaluated potential nonlinear dose-response relationships and assessed the robustness of findings through subgroup and sensitivity analyses. ## Materials and methods ### Data source and study population Data from the 2004 National Health Interview Survey (NHIS), a nationally representative cross-sectional survey of the noninstitutionalized US population conducted by the National Center for Health Statistics (NCHS) was used in this study. The NHIS uses a multistage stratified sampling design to generate population-representative estimates of the United States adult population [[16](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref016)]. Participants were linked to mortality status through December 31, 2019, using the National Death Index Linked Mortality Files. To achieve this, the NCHS uses a probabilistic mortality matching scheme to create the Linked Mortality File [[17](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref017)]. Among 94,597 participants in the 2004 survey cycle, we included those aged 18 years or older with complete data on sleep duration, heart disease, mortality follow-up, and study covariates (n = 3,287). Heart disease (yes, no) was assessed based on the information provided on “Ever been told you had coronary heart disease,” “Ever been told you had a heart condition/disease,” and “Ever been told you had a heart attack.” These data are publicly available from the Center for Disease Control and Prevention website and have been approved by the NCHS’ ethics review board. There is no human/animal involved in this study. ### Exposure assessment The primary exposure was self-reported sleep duration, assessed by the question: “On average, how many hours of sleep do you get in a 24-hour period?” Sleep duration was categorized as ≤6 hours (short), 7–8 hours, and ≥9 hours (long) per night, an adaptation of existing recommendations [[15](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref015),[18](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0362657#pone.0362657.ref018)]. To evaluate potential nonlinear associations and avoid information loss from categorization, secondary analyses modeled sleep duration as a continuous exposure. ### Outcome assessment The primary outcomes were all-cause, heart disease-related (ICD-10 codes I00–I09, I11, I13, I20–I51), and non-heart disease-related mortality during follow-up. For cause-specific analyses, deaths from causes other than the outcome of interest were censored at time of death. Survival time was calculated from the date of NHIS interview to date of death or administrative censoring on December 31, 2019, whichever occurred first. ### Study covariates Sociodemographic variables included age ( 4.99). Health behavior variables included smoking and drinking status (current, former, never), physical activity (light/moderate, never/unable), and b
## Related Clinical Research

- [Smartwatch AI approximates office blood-pressure screening for undiagnosed hypertension](https://medichelpline.com/clinical-feed/nature-0-harnessing-smartwatches-to-spot-undiagnosed-hypertension.md)
- [Multi-omics prediction of hypertension using proteomic, metabolomic scores and blood pressure PRS](https://medichelpline.com/clinical-feed/medrxiv-17-multi-omics-models-for-hypertension-prediction-using-blood-pressure-prs-and.md)
- [Therapeutic patient education reduces one-year major cardiovascular events in Tunisian CHD cohort](https://medichelpline.com/clinical-feed/plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart.md)
- [Cardiovascular risk and mortality after statin initiation: achieved LDL and non‑HDL levels in a 3‑](https://medichelpline.com/clinical-feed/plos-medicine-0-risk-of-cardiovascular-events-and-mortality-associated-with-ldl-and-non-hdl.md)
- [Hypertension prevalence and sex disparities in Sri Lanka: findings from the Sri Lanka STEPS 2021 s](https://medichelpline.com/clinical-feed/plos-one-13-prevalence-associations-and-sex-related-disparities-of-hypertension-in-south.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.